How do genes influence the development of chronic idiopathic thrombocytopenic purpura?

Using epigenetics to manipulate cancer cells

Overcoming the barriers of the P53 dysfunction to cure blood cancers

Exciting new immunosuppressive therapy treatment for aplastic anaemia

Promising new strategy for treating children with acute lymphocytic leukaemia

Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features

Engineered cells to target multiple myeloma

Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes

Cancer Core Europe: where did it come from and what is its future?

Highlights of the EurocanPlatform Project

NCRI 2015 highlights

HVEM expression in melanoma metastasis: prognosis correlation